Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $91 which represents a slight increase of $1.06 or 1.18% from the prior close of $89.94. The stock opened at $90.59 and touched ...
The Macomb Daily on MSN2d
Macomb mom collaborates on children’s book for breast cancer familiesThe colorful picture book is helping parents of young children deal with the difficult journey that follows a breast cancer ...
Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $89.88 which represents a slight increase of $0.74 or 0.83% from the prior close of $89.14. The stock opened at $90.19 and ...
Gilead and Terray Will Leverage Terray’s tNova ... have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets.
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will ...
Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Terray Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule ...
Velia Therapeutics has announced it is winding down its operations while staying loyal to the therapeutic potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback